Characteristics, primary treatment, and survival of MDS/MPN with neutrophilia: a population-based study.

Blood Adv · 2023 · PMC10761362 · PMID 37934881

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Although results favoring alloHSCT are highly significant, this finding should be interpreted cautiously owing to the likely selection of fit patients eligible for an alloHSCT and lead-time bias (ie, patients living long enough to receive an alloHSCT).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.